S. M. Ahn and E. S. Choe, Activation of group I metabotropic glutamate receptors increases serine phosphorylation of GluR1 alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the rat dorsal striatum, J. Pharmacol. Exp. Ther, vol.329, pp.1117-1126, 2009.

J. J. Anderson, M. J. Bradbury, D. R. Giracello, D. F. Chapman, G. Holtz et al., In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine), Eur. J. Pharmacol, vol.473, pp.35-40, 2003.

M. Amalric, Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease, Curr. Opin. Pharmacol, vol.20, pp.29-34, 2015.

P. Bagga, A. N. Chugani, K. S. Varadarajan, and A. B. Patel, In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment, J. Neurochem, vol.127, pp.365-377, 2013.

F. Blandini, G. Nappi, C. Tassorelli, and E. Martignoni, Functional changes of the basal ganglia circuitry in Parkinson's disease, Prog. Neurobiol, vol.62, pp.63-88, 2000.

D. Centonze, P. Calabresi, P. Giacomini, and G. Bernardi, Neurophysiology of Parkinson's disease: from basic research to clinical correlates, Clin. Neurophysiol, vol.110, pp.2006-2013, 1999.

C. Chassain, G. Bielicki, C. Carcenac, A. C. Ronsin, J. P. Renou et al., Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A 1 H nuclear MRS study, NMR Biomed, vol.26, pp.336-347, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00858273

C. Chassain, C. Melon, P. Salin, F. Vitale, S. Couraud et al., Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats, J. Neurochem, vol.136, pp.1004-1016, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02332054

C. Chassain, G. Bielicki, E. Durand, S. Lolignier, F. Essafi et al., Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse, J. Neurochem, vol.105, pp.874-882, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01602181

M. Chiamulera, A. Epping-jordan, C. Zocchi, C. Marcon, S. Cottiny et al., Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice, Nat. Neurosci, vol.4, pp.873-874, 2001.

N. Dehorter, C. Guigoni, C. Lopez, J. Hirsch, A. Eusebio et al., Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons, J. Neurosci, vol.29, pp.7776-7787, 2009.

A. H. Evans, A. P. Strafella, D. Weintraub, and M. Stacy, Impulsive and compulsive behaviors in Parkinson's disease, Mov. Disord, vol.24, pp.1561-1570, 2009.

S. Fenu, J. Wardas, and M. Morelli, Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease, Behav. Pharmacol, vol.20, pp.363-379, 2009.

L. Fourgeaud, S. Mato, D. Bouchet, A. Hémar, P. F. Worley et al., A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens, J. Neurosci, vol.24, pp.6939-6945, 2004.

W. Francesconi, M. Cammalleri, and P. P. Sanna, The metabotropic glutamate receptor 5 is necessary for late-phase long-term potentiation in the hippocampal CA1 region, Brain Res, vol.1022, pp.12-18, 2004.

D. C. German, K. Manaye, W. K. Smith, D. J. Woodward, and C. B. Saper, Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization, Ann. Neurol, vol.26, pp.507-514, 1989.

C. M. Gladding, S. M. Fitzjohn, and E. Molnár, Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms, Pharmacol. Rev, vol.61, pp.395-412, 2009.

Y. Goto and A. A. Grace, Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior, Nat. Neurosci, vol.8, pp.805-812, 2005.

S. N. Haber, J. L. Fudge, and N. R. Mcfarland, Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum, J. Neurosci, vol.20, pp.2369-2382, 2000.

A. A. Herrold, R. M. Voigt, and T. C. Napier, mGluR5 is necessary for maintenance of methamphetamine-induced associative learning, Eur. Neuropsychopharmacol, vol.23, pp.691-696, 2013.

V. Herzig and W. J. Schmidt, Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine, Neuropharmacology, vol.47, pp.973-984, 2004.

V. Herzig, E. M. Capuani, K. A. Kovar, and W. J. Schmidt, Effects of MPEP on expression of food-, MDMA-or amphetamine-conditioned place preference in rats, Addict. Biol, vol.10, pp.243-249, 2005.

J. P. Huston, M. A. Silva, B. Topic, and C. P. Müller, what's conditioned in conditioned place preference?, Trends Pharmacol. Sci, vol.34, pp.162-166, 2013.

S. Ikemoto, Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex, Brain. Res. Rev, vol.56, pp.27-78, 2007.

R. Ito, T. W. Robbins, and B. J. Everitt, Differential control over cocaine-seeking behavior by nucleus accumbens core and shell, Nat. Neurosci, vol.7, pp.389-397, 2004.

J. Jankovic and W. Poewe, Therapies in parkinson's disease, vol.25, pp.433-447, 2012.

Z. Jia, Y. Lu, J. Henderson, F. Taverna, C. Romano et al., Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5, Learn. Mem, vol.5, pp.331-343, 1998.

K. Kawaai, K. Tominaga-yoshino, T. Urakubo, N. Taniguchi, Y. Kondoh et al., Analysis of gene expression changes associated with long-lasting synaptic enhancement in hippocampal slice cultures after repetitive exposures to glutamate, J. Neurosci. Res, vol.88, pp.2911-2922, 2010.

S. J. Kish, A. Rajput, J. Gilbert, L. J. Chang, K. Shannak et al., Elevated g-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: correlation with striatal dopamine loss, Ann. Neurol, vol.20, pp.26-31, 1986.

G. F. Koob and N. D. Volkow, Neurocircuitry of addiction, Neuropsychopharmacology, vol.35, pp.217-238, 2010.

J. Kotlinska and M. Bochenski, Pretreatment with group I metabotropic glutamate receptors antagonists attenuates lethality induced by acute cocaine overdose and expression of sensitization to hyperlocomotor effect of cocaine in mice, Neurotox. Res, vol.19, pp.23-30, 2011.

M. Kuwajima, R. A. Hall, A. Aiba, and Y. Smith, Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus, J. Comp. Neurol, vol.474, pp.589-602, 2004.

J. Y. Lee, E. S. Choe, C. H. Yang, K. H. Choi, J. H. Cheong et al., The mGluR5 antagonist MPEP suppresses the expression and reinstatement, but not the acquisition, of the ethanol-conditioned place preference in mice, Pharmacol. Biochem. Behav, vol.140, pp.33-38, 2016.

N. Lindefors and U. Ungerstedt, Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons, Neurosci. Lett, vol.115, pp.248-252, 1990.

Y. M. Lu, Z. Jia, C. Janus, J. T. Henderson, R. Gerlai et al., Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP, J. Neurosci, vol.17, pp.5196-5205, 1997.

G. Mannaioni, M. J. Marino, O. Valenti, S. F. Traynelis, and P. J. Conn, Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function, J. Neurosci, vol.21, pp.5925-5934, 2001.

C. Melon, C. Chassain, G. Bielicki, J. P. Renou, L. Kerkerian-le-goff et al., Progressive brain metabolic changes under deep brain stimulation of subthalamic nucleus in parkinsonian rats, J. Neurochem, vol.132, pp.703-712, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01431990

C. Nitsch and R. Riesenberg, Synaptic reorganisation in the rat striatum after dopaminergic deafferentation: an ultrastructural study using glutamate decarboxylase immunocytochemistry, Synapse, vol.19, pp.247-263, 1995.

O. Ouachikh, W. Dieb, F. Durif, and A. Hafidi, Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area, Behav. Brain Res, vol.252, pp.24-31, 2013.

O. Ouachikh, W. Dieb, F. Durif, and A. Hafidi, Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats, Behav. Brain Res, vol.262, pp.1-7, 2014.

L. Pomierny-chamio?o, K. Rup, B. Pomierny, E. Niedzielska, P. W. Kalivas et al., Metabotropic glutamatergic receptors and their ligands in drug addiction, Pharmacol. Ther, vol.142, pp.281-305, 2014.

O. Rascol, S. Fox, F. Gasparini, C. Kenney, T. D. Paolo et al., Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias, Parkinsonism Relat. Disord, vol.20, pp.947-956, 2014.

N. Roohi, A. Sarihi, S. Shahidi, M. Zarei, and A. Haghparast, Microinjection of the mGluR5 antagonist MTEP into the nucleus accumbens attenuates the acquisition but not expression of morphine-induced conditioned place preference in rats, Pharmacol. Biochem. Behav, vol.126, pp.109-115, 2014.

P. Samadi, L. Gregoire, M. Morissette, F. Calon, A. Tahar et al., Beí dard, T. Di Paolo, mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys, Neurobiol. Aging, vol.29, pp.1040-1051, 2008.

R. Sanchez-pernaute, J. Wang, D. Kuruppu, L. Cao, W. Tueckmantel et al., Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates, Neuroimage, vol.42, pp.248-251, 2008.

S. S. Schwarz and W. J. Freed, Brain tissue transplantation in neonatal rats prevents a lesion-induced syndrome of adipsia, aphagia and akinesia, Exp. Brain. Res, vol.65, pp.449-454, 1987.

I. Tkác, P. G. Henry, P. Andersen, C. D. Keene, W. C. Low et al., Highly resolved in vivo 1H NMR spectroscopy of the mouse brain at 9.4 T, vol.52, pp.478-484, 2004.

M. M. Veeneman, H. Boleij, M. H. Broekhoven, E. Snoeren, M. G. Masip et al., Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine, Psychopharmacology (Berl.), vol.214, pp.863-876, 2011.

V. Voon, A. R. Mehta, and M. Hallett, Impulse control disorders in Parkinson's disease: recent advances, Curr. Opin. Neurol, vol.24, pp.324-330, 2011.

D. Weintraub, J. Koester, M. N. Potenza, A. D. Siderowf, M. Stacy et al., Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients, Arch. Neurol, vol.267, pp.589-595, 2010.